Follow
Ke Wu
Ke Wu
Associate Director, AbbVie
Verified email at abbvie.com
Title
Cited by
Cited by
Year
Multifunctional Microporous MOFs Exhibiting Gas/Hydrocarbon Adsorption Selectivity, Separation Capability and Three‐Dimensional Magnetic Ordering
K Li, DH Olson, JY Lee, W Bi, K Wu, T Yuen, Q Xu, J Li
Advanced Functional Materials 18 (15), 2205-2214, 2008
1712008
Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent
KE Wu, J Li, W Wang, DA Winstead
Journal of pharmaceutical sciences 98 (7), 2422-2431, 2009
1652009
Crystalline mesophases: structure, mobility, and pharmaceutical properties
E Shalaev, K Wu, S Shamblin, JF Krzyzaniak, M Descamps
Advanced drug delivery reviews 100, 194-211, 2016
552016
Precipitation of a biodegradable polymer using compressed carbon dioxide as antisolvent
K Wu, J Li
The Journal of Supercritical Fluids 46 (2), 211-216, 2008
372008
Freezing of aqueous solutions and chemical stability of amorphous pharmaceuticals: water clusters hypothesis
E Shalaev, A Soper, JA Zeitler, S Ohtake, CJ Roberts, MJ Pikal, K Wu, ...
Journal of Pharmaceutical Sciences 108 (1), 36-49, 2019
262019
Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
AV Gore, K Karami, K Wu, RS Graham, SW Smith
US Patent 8,772,245, 2014
152014
A new hydrate of cyclosporine: structural and physicochemical characterization
K Wu, A Gore, R Graham
Journal of Pharmaceutical Sciences 107 (12), 3070-3079, 2018
92018
Water structure in glycerol: Spectroscopic and computer simulation investigation of hydrogen bonding and water clustering
K Wu, S Feng, A Hedoux, E Shalaev
Journal of Molecular Liquids 355, 118916, 2022
82022
Suspension compositions of cyclosporin A for subconjunctival and periocular injection
AV Gore, H Hou, CP Pujara, S Neervannan, K Wu
US Patent 10,780,048, 2020
82020
Quality assessment of API in semisolid topical drug products
K Wu, T Yeoh, YL Hsieh, DW Osborne
The Role of Microstructure in Topical Drug Product Development, 109-154, 2019
82019
7-[3, 5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof
GF Ambrus, K Karami, K Wu
US Patent 8,629,185, 2014
82014
Best Practices and guidelines (2022) for Scale-up and Tech transfer in Freeze-Drying based on Case Studies. Part 1: challenges during Scale up and transfer
S Tchessalov, E Shalaev, B Bhatnagar, S Nail, A Alexeenko, F Jameel, ...
AAPS PharmSciTech 24 (1), 11, 2022
72022
Prostamide-containing intraocular implant
PM Hughes, J Shen, MR Robinson, DF Woodward, RM Burk, H Liu, ...
US Patent 9,289,413, 2016
72016
Cyclosporin A form 2 and method of making same
K Wu, SW Smith
US Patent 8,796,221, 2014
42014
Prostamide-containing intraocular implant
PM Hughes, J Shen, MR Robinson, DF Woodward, RM Burk, H Liu, ...
US Patent 9,889,142, 2018
32018
Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof
K Wu, GF Ambrus
US Patent 9,353,079, 2016
32016
Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof
K Wu, S Feng, TK Karami, SW Smith
US Patent 9,120,738, 2015
32015
Best practices and guidelines (2022) for scale-up and technology transfer in freeze drying based on case studies. Part 2: past practices, current best practices, and …
S Tchessalov, E Shalaev, B Bhatnagar, S Nail, A Alexeenko, F Jameel, ...
AAPS PharmSciTech 24 (4), 96, 2023
22023
Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form
K Wu, A Gore, R Graham, R Meller
Journal of Pharmaceutical Sciences 108 (10), 3233-3239, 2019
22019
7-[3, 5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof
GF Ambrus, TK Karami, K Wu
US Patent 9,181,176, 2015
22015
The system can't perform the operation now. Try again later.
Articles 1–20